Discover 1,944 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,944
Active & ResponsiveNew
Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study
for
Cerebral Palsy, Typically Developing Children
Location: Fort Worth TX
Sponsor: Cook Children's Health Care System
Sex: All
Age: 6 - 20
Code: NCT07567053
Recruiting
Active & Responsive
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
for
Lymphoid Leukemia
Location: Fort Worth TX, Dallas TX, St Louis MO, Tucson AZ,
Sponsor: Stanford University
Sex: All
Age: 0 - 26
Code: NCT05865301
Recruiting
Active & Responsive
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
for
Congenital Adrenal Hyperplasia,
Location: Fort Worth TX, Chicago IL, Minneapolis MN, Ann Arbor MI,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 1 - 17
Code: NCT07159841
Phase 2, Phase 3, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Fort Worth TX, Dallas TX, Austin TX, Oklahoma City OK,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase 3, Recruiting
Active & Responsive
Clarifying the Optimal Application of SLT Therapy Trial
for
Glaucoma and Ocular Hypertension
Location: Fort Worth TX, Nashville TN, Sheridan CO, Peoria IL,
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT04967989
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
for
Advanced Non-squamous Non-small-cell Lung Cancer,
Location: Fort Lauderdale FL, Austin TX, Baytown TX, Clermont FL,
Sponsor: Genelux Corporation
Sex: All
Age: 18+
Code: NCT06463665
Phase 2, Recruiting
Active & Responsive
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Fort Worth TX, DeSoto TX, St Louis MO, Decatur GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07412756
Phase 3, Recruiting
Active & Responsive
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
for
Hypertension
Location: Fort Worth TX, Houston TX, Bartlesville OK,
Sponsor: SoniVie Inc.
Sex: All
Age: 22 - 70+
Code: NCT06559891
Recruiting
Active & Responsive
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
for
Smoking Cessation
Location: Fort Worth TX, Dallas TX, Austin TX, Huston TX,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07766655
Phase 3, Recruiting
Active & Responsive
Assessment of CCM in HF With Higher Ejection Fraction
for
Heart Failure, Heart Failure With Preserved Ejection Fraction,
Location: Fort Worth TX, Dallas TX, Austin TX, Houston TX,
Sponsor: Impulse Dynamics
Sex: All
Age: 18+
Code: NCT05064709
Recruiting
Active & Responsive
A Study to Evaluate Efficacy, Safety, and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
for
Chronic Pruritus of Unknown Origin
Location: Grapevine TX, Sugarland TX, San Antonio TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07811869
Phase 3, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Fort Worth TX, Dallas TX, Lewisville TX, Mesquite TX,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase 3, Recruiting
Active & Responsive
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
for
Angiokeratomas
Location: Southlake TX, Dawsonville GA
Sponsor: Palvella Therapeutics, Inc.
Sex: All
Age: 6+
Code: NCT07552077
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis